These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 5504558

  • 1. [Therapy of parkinsonian syndromes with L-dopa. Results and prospects].
    Fazio C.
    Sist Nerv; 1970; 22(2):61-6. PubMed ID: 5504558
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment with L-dopa in Parkinsonian syndromes].
    De Renzi E, Pieczuro A.
    Sist Nerv; 1970; 22(1):1-11. PubMed ID: 5502951
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of parkinsonism with the drug L-DOPA].
    Stoliarova LG, Kistenev BA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):199-205. PubMed ID: 4795170
    [No Abstract] [Full Text] [Related]

  • 5. Amantadine hydrochloride in treatment of Parkinsonism.
    Nagaswami S, Nagaswami R.
    Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
    [No Abstract] [Full Text] [Related]

  • 6. [The Rorschach test in parkinsonian patients. Its course during treatment with L dopa. Its prognostic value].
    Sevilla M, Vernet JP, Becle J, Darcourt G.
    Ann Med Psychol (Paris); 1973 May; 1(5):577-608. PubMed ID: 4761931
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Results of treatment of Parkinsonism with L-dopa].
    De Divitiis E, D'Andrea F, Signorelli CD.
    Sist Nerv; 1970 May; 22(2):99-108. PubMed ID: 5504563
    [No Abstract] [Full Text] [Related]

  • 11. [The treatment of Parkinson's syndrome with L-dopa].
    Völler GW, Kerstan J.
    Nervenarzt; 1970 Mar; 41(3):138-44. PubMed ID: 5447886
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cerebrospinal fluid N-acetyl neuraminic acid in Parkinson's disease, before and after L-dopa therapy.
    Lipman IJ, Papadopoulos NM.
    Dis Nerv Syst; 1973 Jan; 34(1):59-62. PubMed ID: 4709194
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Study of L-dopa treatment and its principal side effects in aged subjects].
    Antonini F, Baroni A, Bucalossi A, Roveyaz L.
    Gerontol Clin (Basel); 1972 Jan; 14(5):297-309. PubMed ID: 4144357
    [No Abstract] [Full Text] [Related]

  • 17. DOPA in Parkinson's disease.
    Lancet; 1969 Apr 26; 1(7600):871-2. PubMed ID: 4180531
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. L-DOPA therapy in drug-induced parkinsonism evaluated by the method measuring the facial expression.
    Kimura N, Tsukue I.
    Hiroshima J Med Sci; 1971 Mar 26; 20(1):55-63. PubMed ID: 5121129
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.